Virginia Allen Portner

Array ( [id] => 9625998 [patent_doc_number] => 08795673 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-05 [patent_title] => 'Preparation of maytansinoid antibody conjugates by a one-step process' [patent_app_type] => utility [patent_app_number] => 13/434451 [patent_app_country] => US [patent_app_date] => 2012-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17400 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13434451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8416688 [patent_doc_number] => 20120244188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'Treatment of Sensory Disturbance Disorders' [patent_app_type] => utility [patent_app_number] => 13/425053 [patent_app_country] => US [patent_app_date] => 2012-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 28092 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13425053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8429699 [patent_doc_number] => 20120251574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'Endopeptidase and Neurotoxin Combination Treatment of Multiple Medical Conditions' [patent_app_type] => utility [patent_app_number] => 13/425229 [patent_app_country] => US [patent_app_date] => 2012-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 25602 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13425229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8429698 [patent_doc_number] => 20120251573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'Endopeptidase Treatment of Neuroendocrine Disorders' [patent_app_type] => utility [patent_app_number] => 13/425099 [patent_app_country] => US [patent_app_date] => 2012-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21271 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13425099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8429701 [patent_doc_number] => 20120251575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'Endopeptidase Treatment of Involuntary Movement Disorders' [patent_app_type] => utility [patent_app_number] => 13/425253 [patent_app_country] => US [patent_app_date] => 2012-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 30958 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13425253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8265816 [patent_doc_number] => 20120165244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'METHODS FOR BINDING LEWIS Y ANTIGEN' [patent_app_type] => utility [patent_app_number] => 13/418577 [patent_app_country] => US [patent_app_date] => 2012-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 8613 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13418577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9362722 [patent_doc_number] => 20140072595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-13 [patent_title] => 'GENE EXPRESSION AND ERADICATION SYSTEM IN HELICOBACTER PYLORI' [patent_app_type] => utility [patent_app_number] => 14/003786 [patent_app_country] => US [patent_app_date] => 2012-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 22373 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14003786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10057541 [patent_doc_number] => 09096886 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-04 [patent_title] => 'Method for the determination of botulinum neurotoxin biological activity' [patent_app_type] => utility [patent_app_number] => 14/004259 [patent_app_country] => US [patent_app_date] => 2012-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10320 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14004259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10954820 [patent_doc_number] => 20140357842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-04 [patent_title] => 'YERSINIA OUTER PROTEIN M (YOPM) IN THE TREATMENT OF PSORIASIS' [patent_app_type] => utility [patent_app_number] => 14/344395 [patent_app_country] => US [patent_app_date] => 2012-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6513 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9311587 [patent_doc_number] => 08652804 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-18 [patent_title] => 'Transcription factor-based biosensors for detecting dicarboxylic acids' [patent_app_type] => utility [patent_app_number] => 13/399744 [patent_app_country] => US [patent_app_date] => 2012-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12783 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13399744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8989308 [patent_doc_number] => 20130216589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'ORAL VACCINE FOR AQUATIC ANIMALS' [patent_app_type] => utility [patent_app_number] => 13/399161 [patent_app_country] => US [patent_app_date] => 2012-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4508 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13399161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8346811 [patent_doc_number] => 20120207734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'Methods of Inhibiting Aberrant Blood Vessel Formation Using Opioid Retargeted Endpeptidases' [patent_app_type] => utility [patent_app_number] => 13/371914 [patent_app_country] => US [patent_app_date] => 2012-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 60893 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13371914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8346821 [patent_doc_number] => 20120207743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'Inhibiting Aberrant Blood Vessel Formation Using Retargeted Endopeptidases' [patent_app_type] => utility [patent_app_number] => 13/372018 [patent_app_country] => US [patent_app_date] => 2012-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 99954 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13372018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8490049 [patent_doc_number] => 20120289456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'ANTIMICROBIAL PROTEIN COMPOSITIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/370344 [patent_app_country] => US [patent_app_date] => 2012-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5364 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13370344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9285721 [patent_doc_number] => 08642047 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'Non-protein stabilized Clostridial toxin pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 13/369632 [patent_app_country] => US [patent_app_date] => 2012-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14261 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13369632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8358662 [patent_doc_number] => 20120213821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'NOVEL METHOD FOR ISOLATING ENDOTOXINS' [patent_app_type] => utility [patent_app_number] => 13/368697 [patent_app_country] => US [patent_app_date] => 2012-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2333 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13368697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8186613 [patent_doc_number] => 20120115836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'STABLE LIQUID FORMULATIONS OF ANTI-INFECTIVE AGENTS AND ADJUSTED ANTI-INFECTIVE AGENT DOSING REGIMENS' [patent_app_type] => utility [patent_app_number] => 13/351030 [patent_app_country] => US [patent_app_date] => 2012-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10255 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115836.pdf [firstpage_image] =>[orig_patent_app_number] => 13351030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8138555 [patent_doc_number] => 20120093827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'TREATMENT OF AUTOIMMUNE DISORDERS WITH A NEUROTOXIN' [patent_app_type] => utility [patent_app_number] => 13/332239 [patent_app_country] => US [patent_app_date] => 2011-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12420 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20120093827.pdf [firstpage_image] =>[orig_patent_app_number] => 13332239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9363709 [patent_doc_number] => 20140073582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-13 [patent_title] => 'INSECTICIDE CRY PROTEINS OF BACILLUS THURINGIENSIS WITH ANTI-CANCER ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/994687 [patent_app_country] => US [patent_app_date] => 2011-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4740 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13994687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8094805 [patent_doc_number] => 20120083012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'Expression System for Producing Multi-Enzyme Complexes and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/306056 [patent_app_country] => US [patent_app_date] => 2011-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6431 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20120083012.pdf [firstpage_image] =>[orig_patent_app_number] => 13306056 [rel_patent_id] =>[rel_patent_doc_number] =>)